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ABSTRACT

~571

A subgenomic promoter of a positive strand RNA virus is
disclosed which directs the amplified expression of a structural gene in plant tissue. The core region and an upstream
activating domain of the subgenomic promoter are identified. This promoter can be utilized in a modified virus. or in
an appropriate engineered recombinant DNA derivative
which may be chromosomally integrated or maintained as an
episome in transformed cells.
6 Claims, 8 Drawing Sheets
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PLANT TISSUE COMPRISING A
SUBGENOMIC PROMOTER

mosaic virus. Although the (+) strand RNA viruses of plants
and animals are diverse with respect to host range. genome
and roarticle structures. and exact mechanisms of viral
replication. there are some amino acid and nuclei~acid
sequence homologies (reviewed in R. Goldbach (1987)
Microbiol. Sci. 4:197). Amino acid sequence homologies
have been described fbr poliovirus. foot-and-mouth disease
and cowpea mosaic viruses (H. Franssen et. al. (1984)
EMBO J. 32355). and for nonstructural proteins encoded by
brome mosaic virus, alfalfa mosaic virus. tobacco mosaic
virus and Sindbis virus (J. Haseloff et al. (1984) Proc. Nat.
Acad. Sci. USA 81:4358; P. Ahlquist et al. (1985) J. Virol.
53536). The homologous regions within the nonstructural
proteins are believed to reflect mechanistic similaritiesin the
replication of viral nucleic acid and possibly evolutionary
relationships.
The alphaviruses and the Sindbis-like plant viruses also
share a common strategy for synthesis of coat protein (and
in some cases for the synthesis of additional protein(s). That
strategy is the use of an internal promoter to direct the
synthesis of a (+) strand RNA molecule. called a subgenomic RNA. using the (-) strand as template. The subgenomic RNA comprises a subset of sequences found in the
comesponding "genomic" (full-length) RNA. and may be
encapsidated in viral particles. In the case of the brome
mosaic virus (BMV), (+) strand RNA molecules outnumber
the full-length (-) strand template about 100 to I. and
subgenomic and full-length genomic W A S are made in
ap@oximately equimolar amounts (French and Ahlquist
(1987) J. Virol. 61:1457). The subgenomic mRNA. which in
BMV carries only the message for coat protein. is very
effectively translated by the cellular protein synthetic
machinery. For example. gram quantities of BMV-infected
plant tissue synthesize milligram amounts of coat protein (L.
Lane (1981) in Handbook of Plant Mrus Infections and
Comparative Diagnosis, E. Kurstak Ed.. ElsevierNorthHolland, Amsterdam pp. 333-376).
The bromoviruses are a group of (+) strand plant viruses
with tripartite genomes. Included in this grouping are brome
mosaic virus, cowpea chlorotic mosaic virus (CCMV). and
broadbean mosaic virus (BBMV). CCMV and BBMV infect
the dicots cowpeas and broadbeans respectively. and the host
range of BMV is the grasses. including the cereals (L. C.
Lane. (1981) in The Handbook of Plant Wrus Infections and
Comparative Diagnosis. Chapter 12. Elsevier. Amsterdam).
Barley is a common experimental host for BMV. which has
been well characterized.
BMV strain M1 (Madison 1) (P. Ahlquist et al. (1984)
roc. Nat. Acad. Sci. USA 81:7066) is the experimental
system chosen to exemplify the present invention.The BMV
genome is composed of three RNA molecules of unique.
known sequence: RNAl is 3234 bases in length. RNA2 is
2865 bases in length (l? Ahlquist et al. (1984) J. Mol. Biol.
172:369). and RNA3 is about 2114 bases in length (P.
Ahlquist et al. (1981) 5. Mol. Biol. 15323). Complete cDNA
clones have been produced (P. Ahlquist and M. Janda (1984)
Mol. Cell. Biol. 4:2876). RNAs 1 and 2 are individually
encapsidated: RNA3 is encapsidated together with RNA4.
the 876 base subgenomic coat protein message which is
Lane (1974) Adv. Virus
presumed not to replicate in vivo
Res. 19:151). RNA molecules purified from virus particles
and transcripts prepared from cloned viral cDNA sequences
are infectious in the barley protoplast model system (F!
Ahlquist et al. (1984) Proc. Nat. Acad. Sci. USA 81:7066).
Therefore the full range of molecular biological techniques
is available for the analysis of BMV nucleic acid functional
sequences.
-

~ h isi a division
~
of application ser.N ~ 08J296.080,
.
filed Aug. 25. 1994, now U.S. Pat. No. 5.466.788.
FIELD OF THE INVENTION
The field of this invention is the area of molecular
biology. and it relates in particular to the field of (+) strand lo
RNA viruses. The teachings of the Present invention will
enable the use of a viral control sequence, termed a subgenomic promoter. for directed gene expression in the
priate cell host. Specificdly. the subgenomic promoter of
RNAz of brome mosaic virus is exemplified to
the 15
expression of a structural gene in plant tissue.
BACKGROUND OF THE INVENTION
Single-stranded RNA viruses which are capable of replicating in the cytoplasm of host cells are widespread in zo
nature. Those single-stranded viruses with message-sense
genomic RNA molecules are called (+) strand. or positive
strand. RNA viruses. Among the known (+) strand RNA
viruses there are bacteria-specific. animal-specific, and
plant-specific varieties. There is much diversity in the mor- 25
phology of virus particles. coat proteins. genetic
organization, and genome size. The (+) strand RNA viruses
include. but are not limited to. Q-beta bacteriophage, poliovirus and alphaviruses (including Sindbis virus) of animal
cells. and the bromoviruses (including brome mosaic virus) 30
and the comoviruses (including cucumber mosaic virus) of
plants.
A general review of (+) strand virus replication has been
published (E. Strauss and J. Strauss (1983) Curr. Top.
Microbiol. Immunol. 105:l). A brief summary of the steps 35
follows. Virally determined proteins may be required
together with the genomic RNA(S) for infection to occur, or
all the viral proteins required to initiate virus replication may
be synthesized using the incoming viral genomic RNA as
message. There is no DNA intermediate in the replication of 40
the nucleic acid of these viruses; the replication of the
genetic information of a (+) strand RNA virus requires the
RNA-dependent RNA synthetic capability of cells infected
with such viruses. The incoming genomic (+) strand serves
as template for the synthesis of (-) strand molecules. and 45
then progeny (+) strands are synthesized using the (-)
strands as templates. At the latter step there is an amplification of (+) strands over (-) strand molecules. The (+)
strand viral RNA molecule(s) are generally translated. at
least in part. to yield virus-specific replicase.The (-) strands 50
serve as the templates for subsequent synthesis of large
numbers of (+) strands which may carry structural genes and
which are destined to become encapsidated by coat protein.
Structural proteins are translated from genomic RNA or
from subgenomic RNA, depending on the virus. In the 55
instance of the (+) strand viruses with multicomponent RNA
genomes. the RNA molecules may be encapsidated in separate viral particles. in which case the host cell must be
simultaneously infected with each component to yield a
productive infection.
60
The plant (+) strand RNAviruses have been classifiedinto
two supergroups (R. Goldbach (1986) Ann. Rev. Phytopathol. 24:289). The picornavirus-like supergroup includes
comoviruses, nepoviruses. and potyviruses, while the second supergroup includes those viruses which resemble the 65
animal alphavirus Sindbis virus: the tobamoviruses,
tobraviruses, bromoviruses. cucumoviruses. and alfalfa

-
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Experimental manipulations of' the cloned BMV genome
have begun to define regions of functional importance (I?
Ahlquist and R. French (1988) in Domingo. Holland and
Ahlquist (eds.) RNA Genetics Book 2: RNA Variability,
chapter 3. CRC Press. Orlando. Ha.). Both RNAs 1 and 2
and their gene products are required for viral RNA synthesis;
RNAsl and 2 encode nonstructural proteins l a and 2a
respectively. and these proteins determine RNA-dependent
& ~ ~ o l ~ & r a activity.
se
RNA3 encodes nonstruct&al protein 3a and coat protein. but neither RNA3. protein 3a, nor
coat protein is required for viral RNAreplication (R. French
and P. Ahlquist (1986) Science 231:1294). RNA3 can be
modified by the insertion of a foreign gene in place of the
coat protein gene. or by certain deletions. without the loss of
replication ability (U.S. patent application Ser. No. 709,181,
filed Mar. 7, 1985; R. French et al. (1986) Science
23 19294). RNA3 has been well studied because its gene
products are not required for RNA replication (French et al,
1986). There are regions at the 5' and the 3' noncoding ends
of the molecule which have homologs on RNAs 1 and 2, and
it has been proposed that these sequences may function in
viral RNA polymerase recognition, initiation of
encapsidation. protection of the molecules from cellular
nucleases. or a combination of these functions. Deletion
studies using cloned cDNA and in vitro transcripts have
shown that portions of the 5' and the 3' ends are required for
genomic RNA replication. and that there is a graded effect
of deletions in the intercistronic region of RNA3 as well (R.
French and F? Ahlquist (1987) J. Virol. 61: 1457). One feature
of the intercistronic region is an oligo(A) tract. ranging from
14-22 nucleotides in length in natural virus populations (P.
Ahlquist et al. (1981) J. Mol. Biol. 153:23).The subgenomic
promoter of BMV is located in the intercistronic region as
well. Neither the genomic nor the subgenomic promoters of
the BMV are recognized by host RNA polymerases; only
virally infected cells have RNA-dependent RNApolymerase
activity capable of responding to these signals.
W. Miller et al., 1985. Nature 313:68, established that the
production of RNA4. which serves as the message for coat
protein, occurs by initiation of RNA synthesis within the
RNA3 (-) strand molecule. (-) strand RNA3 templates
ending at the BqlII site about 21 bases upstream of the
RNA4 initiation site were able to direct RNA4 production
(Miller et al. (1985); L. Marsh et al. (1987) in Positive
Strand RNA Viruses. New York Alan R. Liss. Inc.. pp.
327-336. These studies and a study by R. French et al.
(1986) Science 23 1:1294. show that deletions and insertions
at or downstream of the SalI site. which is about 17 bases
downstream of the start site. do not interfere with subgenomic mRNA production. French et al, 1986. demonstrated
the expression of suitably inserted foreign genes by the
subgenomic pathway. Thus. BMV subgenomic promoter
activity was thought to be localized to a 37 base region
which in the cDNA clone lies between the BglTI and the SalI
sites. Marsh et al. (1987) also presented evidence from in
vitro experiments that the 5' boundary of the BMV subgenomic promoter activity was not further upstream than the
BglII site about 21 bases upstream of the RNA4 start site.
Marsh et al. (1987) also stated, without evidence. that the
poly(A) tract somewhat further upstream of the RNA4
initiation site improved promoter activity. Both the studies
by Miller et al. (1985) and those by Marsh et al. (1987)
utilized in vitro expression experiments to examine the
requirements of transcription; their results did not indicate
that nucleotide sequence information as far upstream as -95
could contribute to the level of (+) strand mRNA synthesis.
Neither Miller et al. (1985) nor Marsh et al. (1987) reported

activity of subgenomic transcription. since in their
constructs, sequences 5' to the putative promoter were
missing. No published study has described the use of a
subgenomic promoter-containing fragment of nucleic acid
5 which could be transferred to a desired new location to
generate
a novel subpenomic
mRNA.
-
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SUMMARY OF THE INVENTION
The present invention teaches the use of the nucleotide
sequences which function as a subgenomicpromoter of a (+)
strand RNA virus to direct the amplified expression of a
structural gene in plant tissue, animal tissue or protist cells
by RNA-dependent RNA polymerase. This is the first
instance wherein the nucleotide sequences identifying the
core region and an upstream activating domain of the
subgenomic promoter of a (+) strand virus have been identified. This subgenomic promoter can be utilized in a modified virus. a in an appropriately engineered recombinant
cDNA derivative which may be chromosomally integrated
or maintained as an episome in transformed cells. The
invention is exemplified by the subgenomic promoter of
RNA3 of brome mosaic virus (BMV). but the teachings of
the present invention allow a skilled artisan to select and use
subgenomic promoter sequences from similar (+) strand
RNA viruses for use in any desired cell type. The BMV
subgenomic promoter is composed of two parts: the core
promoter. identified by the nucleotide sequence from about
-21 to about +16. as in FIG.2. which is sufficient to direct
subgenomic transcription. and an activating domain. identified by the nucleotide sequence from about -95 to about
-22. as in FIG.2. The activating domain best acts to increase
the level of subgenomic transcription when said activating
domain is located upstream of and in the proper orientation
relative to said core promoter. Subgenomic transcription is
dependent on RNA-dependent RNApolymerase activity and
a (-) strand RNA molecule containing the subgenomic
promoter and the structural gene; for example the BMV
subgenomic promoter is recognized by RNA-dependent
RNA polymerase activities encoded by RNA viruses
including. but not limited to. brome mosaic virus and
cowpea chlorotic mottle virus. Further improvements on the
existing art are that upstream duplication of the activating
domain of the subgenomic promoter can increase the level
of subgenomic transcription over that directed by a single
Copy subgenomic promoter and that multiple copies of the
subgenomic promoter can direct the synthesis of more than
one subgenomic mRNA molecule from one (-) strand RNA
template.
A principal object of the invention is to provide a recombinant DNA molecule containing a DNA copy of the subgenomic promoter of a (+) strand RNA virus and a structural
gene. wherein the expression of said gene is a two step
process: porn of a host cell transcribes a (-) strand RNA
molecule carrying the functional sequence of the subgenomic promoter h d the cornplemen&y sequence of &d
structural gene, wherein the synthesis of message-sense
RNA is under the control of said subgenomic promoter. In
one embodiment, the subgenomic promoter of RNA3 of
brome mosaic virus directs the expression of a downstream
shuctural gene. RNApolymerase I1 of the genetically modifiedplant tissue synthesizes an RNA molecule which is a (-)
sense, functional copy of the subgenomic promoter and a (-)
sense copy of the structural gene. An RNA-dependent RNA
polymerase, which may be viral RNA replicase of BMV.
recognizes the subgenomic promoter and synthesizes a (+)
sense. or functional message-sense. RNA molecule which
can then be translated into protein. The RNA-dependent
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RNA polymerase activity which responds to the BMV
FIG. 4 Effects of 5' deletions on subgenomic promoter
subgenomic promoter on the (-) strand RNA molecule may
activity. The sequence surrounding the 3' proximal RNA
be from brome mosaic virus or cowpea chlorotic mottle
initiation site in derivative pB3SG5. and map of deletions in
virus genetic information, or from a recombinant DNA
derivativespB3SG21.22. and 15 are presentedin this figure.
molecule encoding, for example. the l a and 2a genes of 5 pB3SGl1 is the plasmid which represents the undeleted
BMV. wherein said genes may be translated into protein
sequences. Values given for the molar ratios of
after transcription by RNA polymerase 11 of the host cell in
RNU':RNA3 are the averages of two or more independent
experiments.
response to either constitutive promoter or under the reguFIG. 5 Effects of upstream duplications on subgenomic
latory control of a plant regulatory element.
a method lo promoter activity. Map of the intercistronic region of wildis a further object of the invention to
type RNA3 (wt) and sequences duplicated in RNA3 derivafor the ampiified gene expression in transformed cells
tives pB3IC2. 5. and 6. In each of these derivatives the
posed of the steps of introducing into a desired host cell a
indicated segment of intercistronic sequence is inserted as a
recombinant DNA molecule containing a subgenomic produplication immediately 5' to position 1015 in the RNA3
meter from a (+) strand RNA virus and a structural gene'
sequence. Values given for the molar ratios of RNA4':RNA3
wherein
of the gene is under the
ls are the averages of three independent experiments. For
control of the subgenomic promoter and wherein the exprescomparison. RNA,$:RNA3 ratios obtained with no duplicasion of that gene depends on transcription by host cellular
tions of upstream infomtion are generally about 2.4 for
RNA polymerase II to yield a (-) strand RNA molecule
similar constructions.
brig the active form of the subgenomic promoter and
FIG. 6 Production of multiple subgenomic transcripts
subsequent subgenomic transcription of the gene to yield 20 individual RW derivatives. schematic maps of ~ A Z
active- (+) sense
by RNA-de~en&ntRNA p l y derivatives pB3SG5. 7. 9. 10, 13. and 14. On each line
merase activity. and then translation of the subgenomic
open-hea&d arrows indicate the sites of insertion of additranscript to produce the polypepti& encoded by the smctional copies of the AvaI-Sac1 fragment spanning the RNA4
turd gene. The host polII transcription can be controlled by
initiation site. Above each arrow is given the molar ratio of
a constitutive. inducible or derepressible polU promoter.
25 that subgenomic RNA to the genomic RNAZ derivative.
averaged from two or more independent experiments. Each
In the figures, and throughout the application. the
value is also represented as a histogram bar for visual
sequences which are the subgenomic promoter are presented
comparison.Arrows with filled heads represent the unaltered
as the (+) strand sequences, which will be understood to be
IWA4 promoter in its w i l d - t ~ ~context.
e
The average ratio
the complement of the active subgenomic promoter
30 of subgenomic RNA4 to genomic RNA3 production in
sequences.
wild-type infection under these conditions is 1.2.
BRIEF D E S C m O N OF THE FIGURES
FIG. 7(A) Alignment of the AvaI-SalI sequence of BMV
RNA3 to emphasize the presence of imperfect direct repeats.
FIG. 1presents a schematic map of BMV RNM. NanThis analysis was computer-assisted- The BgII-Sa core
coding regions are shown as a single line. the 3a and coat
genes as open boxes, the oligo(A) as a small filled box. and 35 promoter Sequence is shown within the indicated solid box.
The Coat initiation codon. overlapping the
site. is also
a bent arrow -b the position of the start of sequences
mrked.
encoding subgenomic RNA4. I n keeping with common
FIG. 7(B) Sequence alignment showing the similarity
practice. the sequence of the packaged (+) strand is shown,
among BMV. the animal alphaviruses. cowpea chlorotic
but it should be noted that the complementary sequence
mottle virus (CCMV), and alfalfa mosaic virus (ALMV)
serves as the template for subgenomic RNA synthesis.
genomic W A S near the start of sequences encoding subNumbering in this figure. and in FIGS. 3, 4, 5. and 6,
genomic mRNAs for capsid proteins. There is a large gap in
corresponds to that in the published sequence for RNA3 (P.
each plant virus sequence introduced solely to achieve
Ahlquist et al. (1981) J. Mol. Biol. 153:23). Restriction
alignment with the alphavirus consensus sequence. The bent
endonuclease sites are recognized on the cDNA molecules
45 arrow shows the start of subgenomic RNA sequences and
carrying the RNA3 sequences.
FIG. 2 displays the nucleotide sequence of the A V ~ T - S ~the initiation codons of the BMV and CCMV coat protein
genes are underlined. These alignments were generated by
fragment of the RNA corresponding to the cDNA clone of
computer using published sequences; in no virus other than
brome mosaic virus RNA3. which fragment comprises the
BMV has the actual subgenomic Promoter been e m ~ g c a l l ~
sequence of the BMV subgenomic promoter and the iaitiation site for subgenomic transcription in the (-1 strand RNA so determined. The alphavirus consensus was derived from the
molecule. The restriction sites shown are for the correspondsequences of Sindbis. Middelburg. Sernliki Forest, and ROSS
ing cDNA. Within the sequences shown the AvaI, Bgll[. and
River v h s e s (J. -H. OUet d. (1982) ROC.
Natl. Acad. S C ~ .
SaLI sites bounding the core promoter are overlined and the
USA 79:5235). The ALMV RNA.3 sequence is from Rcoat protein initiation codon and the o l i g o ( ~ )traa are
Barker et al. (1983) Nucleic Acids Res. 11:2881, and the
underlined. A bent arrow marks the start of the subgenomic 55 CCMVRNA3 sequence was determined by Ahlquist e t a ] .
transcript (RNA4). and the sequence of the 5' end of the
(1981) Cell 23:183.
FIG. 8 presents schematic representations of normal RNA
capped RNA4 molecule is given.
V
~ replication
S
an the two-stage expression system which
FIG. 3 Schematic diagram of the regions
the
utilizes the subgenomic Promoter for amplified transcrip
coat gene cDNA in plasmids pB3TP8 (wild-type). pB3SG5.
and pB3SG6. The AvaI-Sac1 fragment duplicated in 60 tion.
FIG. 8A gives the schematic of successive (-) and (+)
pB3SG5 is bracketed over the wild-type sequence and
strand synthesis amplifying viral RNAin normal infection of
shaded in its new locations in pB3SG5 and pB3SG6. hihost cells.
tiation sites for subgenomic RNAs 4 and 4' are shown by
bent arrows. For pB3SG5 and pB3SG6. the RNA4':RNAZ
FIG. 8B gives the schematic for the similar amplification
ratios were 2.4 and 3.3 respectively. For the wild-type 65 of a chromosomal transcript by cytoplasmic synthesis of
plasmid and pB3SG5 the RNA4:RNA3 ratios were 1.2 and
multiple complementary copies from a viral subgenomic
0.4. respectively.
promoter.
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The nontranslatable primary transcript, which itself is a
(-) strand with respect to the coding sequence of the
plant-expressible gene, is synthesized by cellular RNApolymerase II in response to a p l I I promoter. RNA-dependent
RNApolymerase activity, such as that induced by the l a and
2a genes of BMV. is necessary to achieve subgenomic
transcription of a (+) sense
directed by the sub@nomic Promoter sequences Present in active form on the (-1
strand primary transcript RNA molecule- The plant tissue
can be genetically mdified to contain the gene(s) encoding
RNA-d'Tendent RNA ~ o l ~ m e r a sactivity
e
under the regul a t o control
~
of RNA polymerase IL or that activity can be
expressed during viral infection. Because the polarity of the
primary transcript is opposite to its product subgenomic
RNA, translation of appropriately oriented genes only
Occursfrom the
subgenomic
Thus. this
scheme provides
of induction as
as
expression.

8

from about -21 to about +17, as in FIG. 2. When correctly
positioned as is understood in the art, the core promoter is
sufficient to direct the initiation of message synthesis by an
RNA-dependent RNA polymerase so that (+) strand RNA
s molecules are synthesized.
The activating domain of a subgenomicpromoter includes
sequences which increase the activity of the core promoter
allowing for increased synthesis of subgenomic transcripts.
In the case of BMV. the activating domain which can
1 0 increase synthesis of mRNA directed by a subgenomic
promoter. or a subgenomic core promoter. relative to the
levels obtained when only the core promoter sequences are
present, comprises the nucleotide sequence between about
-95 and about -22. as in FIG. 2. Somewhat less activation
1 s is obtained with the sequence from about -74 to about -22.
RNA dependentRNApolymaase herein refers to an RNA
synthetic enzyme which faithfully initiates (+) strand RNA
synthesis in response to an RNA sequence which is a
subgenomic promoter. and which is contained within a RNA
DETAILED DESCRIE'TION OF THE
20 molecule which is (-) sense relative to the coding region of
m
O
N
the associated structural gene. For example. the la and 2a
genes of BMV determine -kN~-dependen;RN~polymerase
The following definitions are provided. in order to remove
activity in cells within which those genes are expressed. and
ambiguities to the intent of scope of their usage in the
that RNA-dependent RNA polymerase activity recognizes
specification and claims.
A,, RNA virus, as used herein, means a viruswhose 25 subgenomicpromoters including. but not limited to. those of
brome mosaic virus and cowpea chlorotic mottle virus.
genome is RNA in single-stranded form, the sing,e strand
The term subgenomic transcription refers herein to the
being a (+). or messenger-sense strand. Replication of the
synthesis of RNA by an RNA-dependent RNA polymerase
viral (+) strand in a cell occurs by a process of direct RNA
replication and is therefore distinguishable from the mecha- 30 wherein said RNA-dependent RNA polymerase uses a (-1
nism of retroviral replication which is characterized by an
strand of RNA as template. and wherein said RNAintermediate step of reverse transcription in the host cell.
dependentRNApolymeraseinitiates the synthesis of mRNA
in response to the nucleOtide sequence
ConThe term subgenomic promoter refers to those sequences
tained within the subgenomic promoter.
within an RNA molecule and at the 5' end of a structural
The term (+) strand RNA refers to RNA which is
gene. which direct messenger RNA synthesis using said 3 s
messenger-sense with respect to coding regionsRNA molecule as the template. A subgenomic promoter is
The term (-) sense RNArefers to sequences which are the
necessary to drive expression of genes using RNA as template; the subgenomic promoter is recognized by an RNAcomplement of (+) sense molecules. For example. the (-)
dependent FWA polymerase, which may be a viral RNA
sense RNA molecule corresponding to a structural gene is
replicase. The promoter itself may be a composite of seg- 40 complementary in sequence to the message. and the (-)
ments derived from more than one source. naturally occursense RNA molecule cannot itself act as a message for the
ring or synthetic. It should be noted that a subgenomic
translation of the corresponding protein.
Homoter is located in relation to the particular gene whose
The term polII promoter herein refers to DNA sequences
b-anscription it initiates. and it is functionally recognized by
at the 5' end of genes which direct the initiation of wanan RNA-dependent RNA polymerase (or viral RNA 45 scription by the DNA-dependent enzyme RNApolymerase
replicase) when it is contained within an RNA molecule of
of plant or animal cells. Promoter sequences are necessary,
the Proper (-1 polarity. The (-1 sense W A ~ o l e c u l econbut not always suEicient. to drive the expression of downtaining the functional COPY of the subgenomic promoter.
stream genes. The promoter itself may be a composite of
which comprises the functional units of core promoter and
segments derived from more than one source. naturally
activating domain. can be synthesized by WA-dependent so occurring or synthetic. Eukaryotic polII promoters are comRNA polymerase using a (+) sense RNA molecule as
monly identified by the presence of DNA sequences
template. or it may have been synthesized by (cehdar) RNA
homologous to the canonical form 5'-TATAA-~'('TP;TKA'
plymerase II as a transcript initiated by a
Promoter-A
box) about 10-30 bp 5' to the location of the 5'-end of the
specific embodiment of the present invention is the subge~ R N A(cap site, +I). bout 30 bp 5' to the TATA box
nomic Promoter of RNA3 of brome mosaic virus (BMV). 55 another promoter component sequence is often. but not
The identifying sequence of the subgenomic promoter of
always. found which is identilied by the presence of DNA
BMV is given in FIG. 2. For consistency herein. the position
sequences homologous to the canonical form 5'-CCAAT-3'.
of the brome mosaic virus subgenomic Promoter has been
For the purposes of the present description. a pol11 promoter
given relative to the start site of the subgenomic mRNA.
is &fined to include DNA sequence extending up to about
which is designated
The BMV subgenomic Fomoter 60 100 bp 5'(-100) to the cap site. Any additional sequences
which may be located 5' to -100, and which may contain
comprises the nucleotide sequence extending from about
-95 to about +17. as in FIG. 2; the sequence comprised
functionality including, but not limited to. that of &anscrip
within the region from about -74 to about +16 also constition activating element or sequences exerting regulation in
tutes a functional subgenomic promoter.
response to environmental stimuli. are considered promoterThe core promoter of a subgenomicpromoter includes the 6 5 associated elements. but for the purposes of this application.
minimum sequence required for function. In the case of
are considered part of the pol11 promoter. even though said
BMV the core promoter comprises the nucleotide sequence
sequences may be recognized by cellular proteins other than
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DNA-dependent RNA polymerase 11. (A polymerase is said
to "recognize" a particular DNA sequence if that sequence
is necessary to or has regulatory effect on initiation of
transcription by the polymerase.) It should be noted that a
pol11 promoter is generally located 5' to the particular gene
whose transcription it initiates. That transcript may be a (+)
sense RNAmolecule which can serve as a message or it may
be a (-) strand RNA molecule which can serve as a template
for subsequent RNA synthesis.
Expression refers to the transcription and translation of a
structural gene so that a protein is made. Gene expression
can be assessed by direct detection of the protein product, by
protein gel electrophoresis or immunological methods, for
example. Oftentimes, expression is assessed by detection of
the mRNA products of transcription. This method is partitularly appropriate for the assessment of transcriptional
control factors. such as promoter elements, since the effects
of nontranscriptionalprocesses, such as protein degradation.
are excluded.
A structural gene refers to the combination of nucleotide
sequences encoding a protein and (some of) the regulatory
sequences which allow expression of that structural gene in
a plant cell or tissue. The term structural gene refers to that
portion of a gene composed of a DNA segment coding for
a protein. polypeptide or portion thereof. possibly including
aribosome binding site andlor translational start codon. The
term can also refer to copies of a structural gene naturally
found within the cell. but artificially introduced. In this case
a structural gene naturally found in a cell may be reintroduced into a cell as part of a chimeric gene having nonnatural regulatory control sequences. for example under the
control of the BMV subgenomic promoter. The structural
gene may encode a protein not normally found in the plant
cell in which the gene is introduced, in which case it is
termed a foreign structural gene. A foreign structural gene
may be derived in whole or part from a bacterial genome or
episome. eukaryotic nuclear or plastid DNA, cDNA. viral
DNA. or chemically synthesized DNA. It is further contemplated that a structural gene may contain one or more
modifications in either the coding segments or in the
untranslated regions which could affect the biological activity or the chemical structure of the expression product. the
rate of expression, or the manner of expression control. Such
modifications include. but are not limited to, insertions.
deletions and substitutions of one or more nucleotides. The
structural gene may constitute an uninterrupted coding
sequence or it may include one or more introns. bounded by
host cell-functional splice junctions. The structural gene
may be a composite of segments derived from a plurality of
sources. naturally occumng or synthetic. That structural
gene may also produce a fusion protein. It is contemplated
that the introduction into host cells of recombinant DNA
containing the structural gene in combination with a subgenomic promoter or with a pollI promoter will include
constructions in which the structural gene is not derived
from the same kind of cell as the host. and constructions
wherein additional copies of naturally occurring genes are
expressed under BMV subgenomic promoter control.
A recombinant DNA molecule is one which has been
either naturally or artificially produced from parts derived
from heterologous sources. which parts may be naturally
occurring or chemically synthesized molecules. and wherein
those parts have been joined by ligation or other means
known to the art.
Plant tissue includes differentiated and undifferentiated
tissues of plants including, but not limited to, roots. shoots.
leaves. pollen. seeds. tumor tissue such as crown galls. and

various forms of aggregations of plant cells in culture such
as embryos and calli. The plant tissue may be in planta. or
in organ, tissue. or cell culture.
The term chemically synthesized. as related to a sequence
of DNA. means that the component nucleotides were
assembled in vitro using nonenzymatic means. Manual
synthesis of DNA may be accomplished using well established procedures (i.e. M. Caruthers (1983) in Methodology
of DNA and RNA Sequencing. Weissman (ed.). Praeger
mfblishers (New York) Chapter 1) or automated synthesis
can be performed using one of a number of commercially
available machines.
Homlogy as used herein. refers to identity of nucleotide
sequences. The extent of homology between DNA
sequences can be empirically determined in DNA hybridization experiments, such as those described in B. Hames
and S. Higgins (1985) Nucleic Acid Hybridization. IRL
Press. Oxford. UK.
Because there is some flexibility with respect to the
sequences canied on BMV RNA3. it was possible to examine how certain RNA sequences in the intercistronic region
contributed to subgenomic promoter activity. It was known
that initiation of subgenomic RNA synthesis does not
require more than 16 bases downstream of the start site (i.e.
3' to the start of RNA4 sequences in the virion-sense RNA)
(W. Miller et al. (1985) Nature 313:68; R. French et al.
(1986) Science 231:1294; L. Marsh et al. (1987) in Positive
Shand RNA Viruses, Man R. Liss, Inc., New York. pp.
327-336). Infectious in vitro transcripts synthesized from
engineered RNA3 cDNA clones were used to determine the
effects of alterations in the primary structure of RNA3. A
restriction map of the cDNA clone of BMV RNA3 and the
nucleotide sequence of the AvaI-SalI region surrounding the
subgenomic transcript start sites are given in FIGS. 1and 2.
A notable feature of the sequence upstream from the subgenomic message start site is an oligo(A) tract which is
conserved at equivalent genomic positions in other members
of the bromovirus group (P. Ahlquist et al. (1981) Cell
23:183: unpublished observations). To determine whether
the oligo(A) tract affects subgenomic promoter activity.
mutant plasmid pB3IC4. which lacks all but one A residue.
was constructed. That in vitro RNA3 transcript possessed
less than 10% of the parental subgenomic promoter activity
in Viro. The length of the oligo(A) tract ranges in length
from 16-22 in natural RNA3 populations (P. ANquist et al.
(1981) J. Mol. Biol. 153:23). In pB3TP8 there are 18 A
residues (M. Janda et al. (1987) Virology 158:259). Subgenomic promoters containing oligo(A) tracts differing in
length from the 18 as in FIG. 2. will be considered functionally equivalent to the BMV subgenomic promoter of
FIG. 2. provided that similar amounts of sequence information flanking the oligo(A) are maintained.
I, the test system. parental RNA_~transcripts produced
progeny (+) strand RNAS at a ratio of RNA4:RNAZ of 1.2.
To separate the effects of sequence changes in the intercistronic region on subgenomic message production from
effects on genomic RNA~amplification. a second subgenomic initiation site was established by inserting the AvaISac1 fragment of cDNA spanning the start site at the XbaI
site of the RNA3 cDNA to create pB3SG5 (FIG. 3).pB3SG5
transcripts were replicated, and directed the synthesis of two
subgenomic RNAs as intended. The subgenomic mRNA
produced from the engineered copy of the subgenomic
promoter (RNAC) was more abundant than both the
genomic RNA3 and the subgenomic mRNA originating
from the wild-type subgenomic promoter. A ratio of
RNA4':RNA3 of 2.4: 1 was obtained from pB3SG5.
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fragment was present, the AvaI-Sac1fragment of RNA3 was
pB3SG6. which contained only one copy of the subgenomic
duplicated at a ClaI site 5' to the normal RNA4 start site in
promoter at the same distal location as that of pB3SG5.
produced subgenomic and genomic RNAs at a ratio of 2.5: 1.
pB3SG7. Both subgenomic promoters were functional, and
as in other cases where there were two copies of the
The sizes of subgenomic RNA species obtained with
pB3SG5 and pB3SG6 were consistent with initiation from 5 subgenomic promoter. the smaller of the subgenomic RNAs
was more abundant. Mutant RNA3 cDNA clones were also
the expected sites in the duplicated promoter sequences.
constructed to test whether more than two subgenomic
Primer extension experiments confirmed that the initiation
promoters were functional in a single RNA3 derivative.
site for subgenomic RNA synthesis was unchanged even
pB3SG9 and pB3SG10 each contained two AvaI-Sac1 subwhen the subgenomic promoter was moved to a new location or was duplicated within the RNA3 cDNA clone. Like lo genomic promoter fragments while pB3SG13 and pB3SG14
wild-type RNA4 (R. Dasgupta et al. (1976) J. Viral. 18:260),
each contained three. It was found that the subgenomic
promoter was active at each location tested. and a distinct
the subgenomic RNA produced from the novel subgenomic
RNA initiation site was capped.
gradient favoring greater accumulation of subgenomic
Further functionality of RNA sequences in the region
WAS
from 3' proximal sites was observed in these experiupstream of the subgenomic RNA start site was examined by 15 ments (FIG. 6). The observed activation of subgenomic
transcription is a consequence of upstream duplications of
determining the effects of a series of internal insertion and
deletion mutations on subgenomic mRNA synthesis in plant
subgenomicpromoter components.
tissue. A second functional subgenomic promoter was estabThe ability of the subgenomic promoter fragment to
lished distal to the intercistronic region; therefore. it was
function in the reverse orientation relative to the surrounding
possible to use deletion analysis to investigate the 5' limits 2o cDNA was tested in pB3SGSR and pB3SG6R. No putative
of sequences contributing to subgenomic RNA synthesis
subgenomic RNA species were observed. In both cases the
without significantaffects on full-length R N A ~accumulation. In protoplast infedions these deletions induced an
inversion caused severe inhibition of RNA3 accumulation.
amount
For SG6R. with its 26 b inverted repeat.
a
obvious progressive decline in subgenomic RNA production
could be detected on overexPosures of the
of
as the deletions extended further 5'. The decreased accumulation must reflect reduced synthesis because the sequence 25 autoradiogra~hs.but SGSR with its 330 bp inverted repeat
of the subgenomic RNA, and therefore its stability. was
never gave detectable RNA3 production. NO internally iniunchanged in the various constructions. The results are
tiated "pseudo-subgenomic" RNA species of negative polarity were detected from either construction.
summarized in FIG. 4. pB3SGl1 carried the AvaI-SalI
fragment containing about 95 bases upstream of through
Computer-assisted sequence inspection revealed that the
about 16 bases downstream of the start of subgenomic 30 120 base AvaI-SalI region of the RNA3 cDNA. which
contains the core promoter and the activating domain of the
transcription. The RNA4':RNA3 ratio of 2.5 was similar to
subgenomic promoter, includes several imperfect direct
that of pB3SG5. which carried the sequence information
repeats (FIG. 7). The 30 bases overlapping and immediately
through the Sac1 site well into the coat protein gene.
pB3SG21. containing subgenomic promoter sequences from
5' to the oligo(A) tract have 67% identity with the BgLII-SalI
the BstXI site about -74 through the SalI site downstream of 35 core promoter region. with the 3' boundary of this duplicathe start site. produced an RNA4':RNA3 ratio similar to the
tion corresponding precisely to the start of the coat protein
RNA4:RNA3 ratio of the wild-type plasmid, but lower than
coding region. Immediately 5' to this duplication is a clearly
that of pB3SG11. Further deletions of the upstream region
related segment which also includes a single-mismatch
gave further decreases in the R N A 4 ' : W ratios. pB3SG15
repeat of the consensus element 5'-AUCUAUGUU-3'. Thus.
was the plasmid with the shorlest subgenomic promoter 40 nearly all of the AvaI-SalI promoter region consists of
repeats or partial repeats of sequences related to the core
fragment (BglII-SalI); the RNAC:RNA3 ratio was 0.3:l.
showing that the efficiency of the truncated subgenomic
promota; punctuated in one area by the oligo(A). Although
promoter was limited. Thus. the 5' end of the core promoter
similar in sequence, the two copies of the core promoter
is no further 5' than -21. and all information necessary for
motif flanking the oligo(A) were clearly not equivalent.
efficient initiation is 3' to about -95. with results similar to 45 While the 3' copy contains a weak but functional promoter,
no subgenomic RNA initiation was detected at the correthat of the wild-type plasmid ratio when only about 74 bases
sponding site in the 5' copy of this motif.
of upstream information are present. Therefore, the BglIISalI fragment. from about -21 to about +16 as in FIG. 2.
As shown in FIG. 7. the oligo(A)/core promoter region of
comprises the BMV subgenomic core promoter. The AvaIBMV W A ' j contains similarities to the analogous regions
SalI fragment, from about -95 to about +16. as in FIG. 2. 50 near the subgenomic mRNA start sites in some other plant
and the BstXI-Sd fragment, from about -74 to about
RNA viruses. including cowpea chlorotic mottle virus
as in HG. 2. both contain activating domain and core
(CCMV) and alfalfa mosaic virus (AMV), BMV is the only
promoter activities of the subgenomic promoter.
(+) strand RNA virus for which the subgenomic promoter
Duplication of subgenomic promoter activating domain
sequences have been determined experimentally.FIG. 7 also
sequences from the RNA3 intercistronic region at a site 55 displays the significant homology of the sequence from the
some 220 bases upstream of the start site for subgenomic
BMV subgenomic promoter region to the consensus
transcription led to a stimulation in subgenomic RNA synsequence from just upstream of the start of alphavirus
thesis. The structures and the RNA4:RNM ratios for wildsubgenomic RNA (taken from J. -H. Ou et al. (1982) Proc.
type and the mutant plasmids is given in FIG. 5. Significant
Natl. Acad. Sci. USA 79:5235-5239); the functionality of
stimulation of subgenomic RNA synthesis was achieved by 60 the alphavirus consensus sequence in directing subgenomic
RNA synthesis has not been tested. The sequence similariduplicating the sequence contained within the activating
domain. an AvaI-BglII fragmenl from about -95 to about
ties shown in FIG. 7 overlap the BMV consensus element
AUCUAUGUU which. with single mismatches. is repeated
-21 of the cDNA of RNA3 upstream of RNA start site.
While the oligo(A) tract contributed to that stimulation. it
three times in the BMV AvaI-SalI fragment (FIG. 7A).
was not required for stimulation to occur.
65 Deletions of the upstream repeated sequences (FIG. 4)
resulted in decreased subgenomic promoter activity.
To determine whether sites other than the XbaI site could
Furthermore. RNA4 synthesis was shown to proceed corsupport subgenomic RNA synthesis when the AvaI-Sac1
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rectly from a CCMV RNA3 when BMV RNAs 1 and 2 were
subgenomic transcription start sites. subgenomic promoters
provided in a co-infection and similarly. co-infections of
equivalent to that of BMV RNA3 can be isolated and used
BMV RNA3 with CCMV RNAs 1 and 2 yield accurately
as described and exemplified herein. The recognized homology and mode of action of RNA-dependent FZNA p l y synthesized RNA4. Previously published studies of BMV
subgenomic transcription were based on in vitro experi- 5 merases allows for the mixed combination of subgenomic
promoter and RNA-dependent RNA polymerase from hetments carried out using extracts made from BMV-infected
erologous sources, or demonstrated herein for BMV and
barley cells (L. Marsh et al. (1987) in Positive Strand RNA
CCMV. However, it will be understood that merences in
Mruses. Alan R. Liss, Inc.. New York; W. Miller et al. (1985)
Nature 313:68). The work of the present invention was
rate of transcription and promoter specificity can lead to
performed using in vivo experiments to study subgenomic lo quantitative differences h expressiA. depending on the
RNA synthesis. The current results demonstrate that the
particular combination of promoter and polymerase
BgllI-SalI region of cDNA for BMV RNA3 has some
employed.
subgenomic promoter activity in vivo, however, sequence
It is an object of this invention to provide a method for the
information upstream of the BgLII site (the AvaI-BglII region
amplified expression in plant tissue of a structural gene
from about -95 to about -21 relative to the start site) 1s under the regulatory control of an FZNA virus subgenomic
constitutes an activating domain which is required for effipromoter. which in one embodiment can be the subgenomic
cient synthesis of subgenomic RNA by RNA-dependent
promoter of brome mosaic virus. The method is composed
RNA polymerase. In addition. the work of the present
of the following steps: introducing into plant tissue a recominvention demonstrated that a fragment of DNA (e.g., the
binant DNA molecule containing the subgenomic promoter
AvaI-SalI fragment) containing the subgenomic promoter 20 and a structural gene such that the expression of said gene
could be moved to a novel location within an RNA sequence
is under the regulatory control of the subgenomic promoter
with subgenomic promoter activity retained. Furthermore.
and the entire combination is of a conventional polII
several subgenomic promoters have now been shown to be
promoter. either constitutive. inducible or derepressible.
functional within a single RNA3 derivative even if located
synthesis by cellular RNA polymerase 11 of a prinmy. (-)
at separate sites leading to a plurality of subgenomic RNA 25 strand transcript containing the subgenomic promoter in its
transcripts. Still further, it was determined that a fragment
active form and the complement of the coding sequence of
carrying the activating domain of a subgenomic promoter
the structural gene. and expression of FZNA-dependent RNA
could be duplicated upstream of the subgenomic promoter
polymerase activity (for example, by the infection of the
with the unexpected result that subgenomic transcription
modified plant tissue with brome mosaic virus, or by inducwas enhanced.
30 ing chromosomally integrated copies of the BMV la and 2a
genes under the control of pol11 promoters). followed by
A principal feature of the present invention is the brome
subgenomic transcription to yield a secondaq. (+) sense
mosaic virus subgenomic promoter. which is identified by
mRNAencoding the structural gene which is then translated
the nucleotide sequence as in FZG. 2, nucleotides -95 to +16
relative to the start site for subgenomic transcription. This
to yield its protein product. This scheme has the advantage
nucleotide sequence was sufficient to direct subgenomic 35 that in the absence of RNA-dependent RNA polymerase
activity the structural gene is completely silent because there
RNA synthesis from a novel site on the viral genome at
is no (+) sense RNA synthesized. and therefore. there can be
wild-type or greater levels. Sequences no more than about
20 bases upstream of the start site sufficed to direct specific
no translation to yield the protein product of that gene.
initiation at a low level; therefore the region between -21
Generally genes under the regulatory control of regulated
and +16 is termed the subgenomic core promoter. Sequences 40 polII promoters and associated sequence elements exhibit
some degree of expression even in the absence of inducing
at least as far as 74, but no more than 95 bases upstream are
required for full promoter activity. The oligo(A) tract within
conditions. Use of a subgenomic promoter is therefore
the region between -21 and -74 is an important functional
useful to prevent expression of a gene which would be lethal
element in full subgenomic promoter activity, and may
for the cell which expresses it. When such a gene is tightly
function as a recognition sequence element or may provide 45 controlled so that it is only expressed after infection with
spacing or flexibility between other elements of the provirus, its expression kills the infected cell before virus
replication and dissemination occur. This process constitutes
moter. The function of the sequence elements with homolan effective means for controlling virus infection in plant
ogy to the consensus element AUCUAUGUU is not known.
tissue, and therefore a way to prevent crop damage and
but analogy to DNA-dependent transcription suggests that
these sequences might be recognized by trans-acting factor 50 economic loss. The advantages of this scheme would be lost
if the control of lethal gene expression were not virtually
(s) to increase the level of subgenomic transcription. Further
increases in the level of subgenomic transcription were
absolute, and are therefore not feasible with prior art pol11
obtained by duplicating the sequence information of the
promoters.
AvaI-BgHl fragment upstream from the start site. as in FIGS.
Another consequence of the use of a subgenomic pro2 and 5. The subgenomic promoter can be used to direct the ss moter is the rapid amplification of expression once an active
expression of a structural gene when the subgenomic proRNA-dependent RNA polymerase is present. The promoter
moter is in a site other than its normal site within the RNA3
is therefore useful to express any gene when a sudden burst
derivative. and enhancement of subgenomic transcription
of expression is desired. For example. rapid but transitory
may be achieved by duplication of the activating domain
expression of high-level herbicide-resistance can be
portion of the subgenomic promoter.
60 obtained by providing a herbicide-resistance gene under
subgenomic promoter control and an RNA-dependent RNA
From the data presented herein. location. isolation and use
of subgenomic promoters from other sources can be readily
polymerase under control of an inducible or derepressible
polII promoter. The latter can be chosen to turn on p l y carried out by those of ordinary skill in the art without undue
merase expression in response to a component in the herexperimentation. The comparative sequence data of FIG. 7
show remarkable homology over a wide range of RNA 65 bicide formulation. Other specific resistances can be regusources known to possess subgenomic promoters. From
lated in a similar manner and will be especially useful where
the resistance is the result of expressing a gene that leads to
such data, together with known or readily obtainable data on
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production of a toxic distasteful or otherwise undesirable
substance. High level. transitory expression of such a gene
can be achieved using an innocuous inducing agent, so as to
produce the desired resistance at precisely the desired Stage
in the host organism's life cycle. Later. for example at 5
harvest. when the gene is not expressed, the undesirable
substance is absent from plant tissue intended for consump
tion.
It will be understood by those of ordinary skill in the art
that the use of subgenomic promoter-structural gene corn- lo
binations is not confined to plants. Positive strand RNA
viruses exist for bacteria and animal cells as well as plants,
and subgenomic promoter homology is seen for both plant
of a structural
and animal viruses.
gene under subgenomic Promoter control can be axom- 15
plished in any transformable cell including. without
limitation, plant cells, animal cells and bacterial cells.
The production of genetically modified plant tissue containing and expressing a structural gene under the banscrip
tional control of the BMV subgenomic Promoter combines 20
the specific teachings of the present disclosure with a variety
of techniques and expedients known in the art. In most
instances. alternative expedients exist for each Stage of the
process. The choice of expedients depends on variables such
as the choice of vector system for the introduction and stable 25
n~aintenance of the expression complex. the cell type,
whether plant, animal or protist, to be modified and, in the
case of plants, the desired regeneration strategy, and the
m i c u l a r structural gene to be used, all of which wesent
iternative process s h s which those of ordinary skiil in the 30
art are able to select and use to achieve a desired result.
Homologs of structural genes or of other sequences may
be identified by the ability of their nucleic acids to crosshybridize under conditions of appropriate stringency as is
well understood in the art. It will be understood that there
may be minor sequence variations within sequences utilized
or disclosed in the present application. It is well known in
the art that some DNA secluences within a larger stretch of
sequence are more impokant than others inVdetermining
functionalitv. A skilled artisan can test allowable variations
in sequence, without undue experimentation. by well known
mutagenic techniques which include. but are not limited to.
those discussed by D. Shortle et al. (1981)Ann. Rev. Genet.
15265; M. Smith (1985) ibid. 19:423; D. Botstein and D.
Shortle (1985) Science 229:1193; by linker scanning
mutagenesis (S. McKnight and R. Kingsbury (1982) Science
217:316) or by saturation mutagenesis (R. Myers et al.
(1986) Science 232:613). These variations may be determined by standard techniques in combination with assay
methods described herein to enable those skilled in the art to
manipulate and bring into utility the functional units of pol11
promoters, structural genes. and subgenomic promoters.
Using the methods described herein the skilled artisan can.
without undue experimentation, test altered sequences
within a subgenomic promoter for retention of function. The
final steps of the preferred embodiment for obtaining genetically modified plant tissue include inserting the expression
complex into a T-DNA-containing vector, and transferring
the recombinant DNA to plant tissue wherein the modified
T-DNA becomes stably integrated as a part of the genome.
Other techniques for transforming plant cells. including
protoplast transformation. elecb-oporation, micro-injection
and agroinfection can be employed.
The following examples are provided for illustrative
purposes only and are not intended to limit the scope of the
invention. The examples utilize many techniques well
known and accessible to those skilled in the arts of molecu-
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lar biology, in the manipulation of recombinant DNA in
plant tissue, and in the culture and regeneration of transformed plants. Techniques for similar manipulations of
recombinant DNA in animal and bacterial cells are well
known. Enzymes are obtained from commercial sources and
are used according to the vendors' recommendations or
other variations known in the art. R
~ buffers.~
~
cultural conditions are also known to the art. References
containing standard molecular biological procedures include
T. Maniatis et al. (1982) Molecular Cloning. Cold Spring
Harbor ~
~cold spring
b ~
~N.Y; ~R. wu
~ b(ed.) ~~
(1979) ~ ~ t ~h .
~68; R. wu
~ et al.~ (eds.) (1983)
~
~
~
~ 100 and~ 101; L.~ eossman
~ and K.
~
Moldave (eds.) Methods Enzymol. (1980) 65; J. Miller (ed.)
(1~r72)E q e h n t s in Molecular Genetics. Cold Spring
~~b~
~
~ cold spring
b ~ ~~N.Y;bold
~ and
~
.
~
Primrose (1981) Principles of Gene Manipulation, University of California Press, Berkeley, Calif.; R. Schlief and P.
Wensink (1982) Practical Methods in Molecular Biology,
Springer-Verlag. Berlin; Glover (ed) (1985) DNA Cloning,
~01s.I and 11.
Press, Oxford, IJK; B. Hames and S.
Higgins (eds.) (1985) Nucleic Acid Hybridization, IRL
Press, Oxford, UK; p, Setlow and A. Hollaender (1979)
Genetic Engineering: Principles and Methods, Vols. 1-4.
Plenum Press, N.Y. Abbreviations and nomenclature. where
employed. are deemed standard in the field and commonly
used in professional journals such as those cited herein.
EXAMPLE 1
This example describes the recombinant DNA molecules
and the cloning strategies used to characterize the BMV

subgenomic promoter sequences.
1.1 Wild-type cDNA Clones of Brome Mosaic
V i s in Transcription Vector Plasmids
Plasmids pBlTP3. pB2TP5, and pB3TP8 contain cDNA
copies of BMV RNAs 1. 2, and 3, respectively, from which
properly initiated, capped and infectious transcripts of the
complete BMV genome can be produced with T7 RNA
polymerase (M. Janda et al. (1987) Virol. 158:259). Other
plasmids used in the construction of RNA3 derivatives were
pB3TP7 (M. Janda et al. (1987) and pB3PM1 (P. Ahlquist
and M. Janda (1984) Mol. Cell. Biol. 4:28762882). Those
plasmids contain the same BMV cDNA region as pB3TP8.
but are linked to a T7 promoter with a single intervening G
residue, and linked directly to an E. coli promoter, respectively. All the above plasmids except pB3M1 are pUC119
derivatives, and so contain the ssDNA replication origin of
bacteriophage M13. allowing recovery of ssDNA forms
after superinfection with suitable helper phage. such as
M13K07 (provided by J. Vieira).
1.2 Plasmid Constructions with Mutant BMV
Constructions
Standard methods were used with minor modifications (T.
Maniatis et al. (1982) Molecular Cloning. Cold Spring
Harbor Laboratory, Cold Spring Harbor. N.Y.). To join
noncomplementary ends of fragments produced by different
restriction endonucleases. 3' protruding ends were trimmed
to bluntness with T4 DNA polymerase. and 3' recessed ends
were extended to bluntness with either the large fragment of
E. coli DNA polymerase I or T4 DNA polymerase.
pB3IC4: E. coli RZ1032 (dut. ung) (T. Kunkel (1985)
Proc. Nat. Acad. Sci. USA 82:488) was transformed with
pB3TPs and dUTP-containing ssDNA was isolated after
superinfection with M13K07. This DNA was used as a
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transcription in the presence of m7GpppG or GpppG, protemplate for oligonucleotide-directed mutagenesis (Kunkel.
1985) to delete 17 of the 18 residues of the pB3TP8
toplast inoculation and incubation. viral RNA extraction and
intercistronic 0ligNA) tract, and the product clones were
analysis and densitometry of the resulting autoradiographs
screened di&Ox~nucleoti&sequencing (M. Biggen
were carried out as described (French and Mquist, 1987).
(1983) Proc. Nat. Acad. Sci. USA 80:3%3). The mutagenic s Each plasmid construction was tested in at least three
oligonucleotide
used
Was
independent experiments. Probes for the (+) strand FWA
SP6
$
~
g
~
~
"
,
~
~
~
e
d were~ a 32P-labelled
~
~
~ transcript
~
~ from
~ subclone
f
~pB3HEl.
~
~
of 3'
which
the 200 base Hinm-EcoRT
boundaq of the core promoter. pB31C4 is the plasmid which
sequences from pB3TP8. Or in
la& the oligo(A) tract in the subgenomic promoter region. 10 terminal RNA3
tain experiments (e.g.. for F'IG. 6 of MS) a similar in vitro
pB3SG5. 5R, 9. 10, ll, 13, 14, 15, 21, 22: Copies of the
''mplementar~ to the Bgm-Sacll region of
Avd-SacI fragment of p B 3 m were inserted as duplicaRNA3.
Denaturing
gel
for negative strand
tions in the indicated sites of the RNA3 ,-DNA region of
genes
RNA
analysis
was
carried
Out On
p B 3 m : pB3SG5: Xbd; pB3SG7: ClaI; pB3SG9: ClaI.
~ b * , pB3SG10: x b a ~ s t u lpB3SG13;
;
c l d xbal, stul; 1s (Maniatis et al.. 1982). Probes for the negative strand RNAs
pB3SG14: N ~ ~aI ,d , su ~
~
analysis
~
~ was~usedito ~ weret in vitro
i transcripts
~
~ from subclones covering the AvaIselect those insertions with the same orientation as the
Sac1 region of BMV RNA3surrounding cDNA. Multiple rounds of cloning were
Primer extension experiments were carried out after
required to construct those dexivatives with multiple inser- 20 inoculation of 106 ptoplasts with transcripts of FWAl and
tions of the subgenomic promoter fragment. In the cases of
RNA2 cDNA clones @B1m and pB2TP5) and transcripts
multiple promoter constructions, the use of the AvaI-Sac1
incubation for
of the appropriate RNA3 cDNA clone.
fragment rather than the smaller AvaI-SalI fragment allowed
24
h
under
continuous
light,
total
nucleic
acids
were isolated
the distinction of the resulting subgenomic RNA species
and dissolved in 15 pl ddH20. 1.5 pl of this nucleic acid was
differentiable in size by gel electrophoresis.
25 mixed
with
1 ng of 5'-32P l a b e l l e d
in the reverse
P~~~~~~ contains the AvaI-Sacl
d(GCGAGTCm(-'TITACC)(complementruyto bases 28-42
orientation at the XbaI site of pB3TW.
of BMV RNA4) in a total volume of 4 pl with 1.5 units of
pB3SG11 contains the AvaI-SalI fragment as a duplicareverse transcriptase (Life Sciences. Inc.) deoxynucleotides
tion at the
site of P B ~ T P ~Similarly.
.
pB3SG15.
each. and final concentrations of 25 mM Tris-cl
at 25
P
~and P~~~~ contain the
~ B@-SaLT.
~ BsX1-Sall,
~
and~ 30 pH 8.3.
* 5 &f MgCl,, 25 &f KC1 and 5 &f m.After
D&I-SalI fragments. respectively.
incubation for 30 min. at 37 C., the products were denatured
pB3SG6.6R: pB3BB1 is a p B 3 m derivative in which a
at 95 C. for mino in an equal volume of 908
site has
&letion from base
the downstream
20 mM EDTA. 0.1% xylene cyanol. 0.1% bromphenol blue.
been i~~trcxluced.
(R.French and P. Mquist 1987) J. viol.
aliquots were electrophoresed on a 12%
and
61:1457). The AvaI-Sac1 fragment of pB3TP8 was intro- 35
polyacrylamide,
8.3 M urea gel. Marker lanes were prepared
duced into the XbaI site of pB3BB1 in the same orientation
as the surrounding cDNA to create pB3Sm, and in the
except that each
contained
pM
a
single &oxynucleotide. and the template was ssDNA prereverse orientation to create pB3SG6R.
pared from phage particles isolated after superinfection of
pB3IC2.3.5.6: In separate constructions, a BamHIlinker
(CGCGGATCCGCG, New England Biolabs) was inserted 40 P
~ E. cozi with
~ phage
~
Sequence comparisons were made with the assistance of
in the AvaI and BglII sites of pB3M1 after filling out the
software
recessed ends with the ~l~~~~D
N
A
~-l-he ~small~
~
~ from
~ the
~ University
~
. of Wisconsin Genetics Computer
PstI-BamHI fragment of each of these plasmids was ligated
with the large PstI-BamHI fragment of pB3BC1 (French and
EXAMPLE 3
Ahlquist. 1987) to yield intermediate plasmids with the 45
cDNA duplications of pB3IC2 and pB3IC3 respectively.
The small PstI-QaI fragment of each plasmid was then
Construction of pB3-SGP and Gene Expression
exchanged for the small PstI-ClaI fragment of pB3TP8 (to
substitute a bacteriophage T7 promoter for the E. coli
hi^ example describes the construction of a cDNA
promoter for in ~ i t r ~ , t r a I l ~ c r i p tto
i ~yield
n ) pB3IC2 and 50 RNA3 derivative which directs the
of chlorampB3IC3- In
addibonal constructions the large EcoRIphenicol acetyl transferase ( C N ) activity under the tranHinc11 fragment P B ~ H S(Rench
~
and Ahlquist. 19g7)
scription control of the BMV subgenomicpromoter. wherein
was ligated with the
AvaI-EcORI fragment of P~~~~~
the expression of the subgenomic promoter-CA'J' gene cornor~B31C4'The1argeBqm-EcoRIfragments of the resultant
is from a novel site on the RNA3 molecule,
plasrnids were ligated individually with the small BamHI- 55
The subgenomic promoter-CAT gene complex is cloned
EcoRI fragment of pB3BCl to yield pB3IC5 and pB3IC6,
as a AvaI-PstI fragment of pB3CA42 (R. French et al. (1986)
respectively.
Science 231:1294). After filling out the single-stranded ends
EXAMPLE 2
with Klenow DNApolymerase. this fragment is cloned into
60 the X b d site of pB3TW after Similar treatment to create
~n Vieo Transcription, Protoplast Inoculations and
flush ends; the resultant plasmid in which the orientation of
RNA Analysis
the subgenomic promoter-CAT gene complex is the same as
This example describes the techniques used to examine
in the surrounding cDNA is
pB3-SGP.
the functionality of BMV wild-type a altered subgenomic
RNA transcripts are introduced into barley protoplasts as
promoter sequences.
65
described in Example 2. CAT gene activity is measured as
Barley protoplasts were isolated as described (L. Loeschdescribed in French et al.. 1986.
Fries and T. Hall (1980) J. Gen. Virol. 47:323). In vitro
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IZKAMPLE 4
Construction of pBMVSGP and TWO-Stage Gene
Expression Controlled by the BMV Subgenomic
Promoter
This example describes the cons&uction of a recombinant
DNA molecule containing the subgenomic promoter of
BMY and the bacterial chloramphenicol acetyltransferase
(CM) gene, such that expression of the CAI' gene is under
the regulatory control of the st~bgenomicpromoter. This
molecule can be used to reduce the BMV subgenomic
promoter-dependent CAT gene into plant tissue by
Illeans lrnownto the art.
of the genetically
fied plant tissue by treating with BMV genomic RNAs to
supply RNA-dependent RNA polymerase activity then turns
on the expression of the CAT gene under the control of the
subgenomic promoter.
The Avd-PstI fragment of pB3CA42 (R.French et al.
(1986) Science 23 1:1294) provides the subgenomic
promoter-cm gene combination. After repairing singlestranded overhangs with Klenow DNA polymerase, this
fragment is inserted at the BamHI site of pGA355+26 (G.
An et al. (1986) Mol. Gen. Genet. 203:245). Restriction
endonuclease digests are performed to choose the product in
which that the PstI-end is adjacent to the nos promoter, a
porn promoter; this recombinant is pBMVSGP. Thus. a
primary transcript directed by the nos promoter will be a (-)
strand with respect to the subgenomic promoter and the CAT
coding region. There is no translation initiation site in the
nos-derived portion of the primary transcript.
pBMVSGP is introduced into tobacco protoplasts using
the technique of electroporation (M.F r o m et al. (1985)
proc. Natl. Acad. Sci. 82:5824). Primary (-) strand transcripts will be constitutively synthesized by cellular RNA
polymerase II.
Subgenomic promoter-dependent expression of CP;T is
accomplished by introducing BMY R N A ~as the source of
RNA-dependent RNA polymerase activity into the genetically modified tobacco protoplasts, as described by L.
Loesch-Fries et al. (1985) Virology 143:626. CAT enzymatic activity is measured as described (French et al.
(1986)).

We claim:
1. Plant tissue comprising a plant cell transformed to
comprise a DNA segment comprising the nucleotide
sequence of a (+) strand plant RNA virus subgenomic core
promoter
the group
of
tobamoviruses, tobraviruses. bromoviruses, cucumovinrses
and alfalfa mosaic virus, wherein said (+) strand RNA virus
comprises a consensus sequence selected from the group
consisting of AUCUAUGUU and sequences having a single
mismatch thereto, a d further comprising an undeviating
domain corresponding to the nucleotide sequence from a
BstX[ site to a BglII site of the cDNA correspondingto the
RNA of FIG. 2, and wherein said activating domain is
positioned 5' to said subgenomic core promoter sequence.
and comprising a plant-expressible structural gene 3' to said
subgenomic core Promoter sequence. said plant-expressible
structural gene being heterologous to the native genes of
said plant tissue. and wherein said plant-expressible structural gene is expressed
2. The plant tissue of claim 1. wherein said subgenomic
promoter is from home mosaic virus.
3. The plant tissue of claim 2. wherein said subgenomic
promoter comprises the subgenomic core promoter
sequence. from a B@ site to a SaUI site as in FIG. 2. and
further comprises the BMV activating domain sequence.
from a BstX site to a SalI site as in FIG. 2. wherein said
activating domain is positioned immediately upstream of
said core promoter.
4. The plant tissue of claim 2, wherein said subgenomic
promoter comprises the core promoter sequence. and further
~0Inprisesan activating domain sequence. from a AvaI site
to a SalI site as in FIG. 2, wherein said activating domain is
positioned immediately upstram of said core promoter.
5. The plant tissue of claim 1. wherein said subgenomic
promoter and said plant-expressible structural gene are not
from the same source.
6. The plant tissue of claim 1,wherein said subgenomic
'Ore
promoter is from 'lfalfa mosaic virus.
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